Cempra Pharmaceuticals, Inc. Reports First Quarter 2013 Financial and Operating Results
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
CHAPEL HILL, N.C., April 25, 2013 -- /PRNewswire/ -- Cempra, Inc. (Nasdaq: CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases, today reported financial results for the first quarter ended March 31, 2013. The company will host a conference call and webcast at 4:30 p.m. EDT, today.
Help employers find you! Check out all the jobs and post your resume.
CHAPEL HILL, N.C., April 25, 2013 -- /PRNewswire/ -- Cempra, Inc. (Nasdaq: CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases, today reported financial results for the first quarter ended March 31, 2013. The company will host a conference call and webcast at 4:30 p.m. EDT, today.
Help employers find you! Check out all the jobs and post your resume.